KBC Group’s Athenahealth, Inc. ATHN Stock Holding History

KBC Group’s Portfolio ATHN Stock Details ATHN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-99,128	Closed	-$13.1M	–	1464
2018 Q4	$13.1M	Buy	99,128 +63,644	+179%	+$8.15M	0.15%	181
2018 Q3	$4.74M	Buy	+35,484	New	+$5.32M	0.04%	446
2018 Q2	–	Sell	-6,344	Closed	-$907K	–	1340
2018 Q1	$907K	Buy	+6,344	New	+$867K	0.01%	813
2017 Q2	–	Sell	-9,075	Closed	-$1.02M	–	1358
2017 Q1	$1.02M	Sell	9,075 -2,870	-24%	-$335K	0.01%	863
2016 Q4	$1.26M	Buy	11,945 +148	+1%	+$15.9K	0.01%	788
2016 Q3	$1.49M	Buy	11,797 +10,816	+1,103%	+$1.38M	0.02%	647
2016 Q2	$135K	Buy	+981	New	+$130K	﹤0.01%	1134

KBC Group's ATHN Position: Q1 2019 in Review

KBC Group sold out of Athenahealth, Inc. (ATHN) in Q1 2019, closing a stake of 99,128 shares — an estimated $13.1M sold.

KBC Group first reported a position in ATHN in Q2 2016 and held it in 7 quarters. The position peaked at $13.1M in Q4 2018. 0 funds tracked by Wall St. Rank hold ATHN as of Q1 2019.

KBC Group reported no remaining Athenahealth, Inc. position as of Q1 2019 after selling out during the quarter.
KBC Group sold 99,128 Athenahealth, Inc. shares in Q1 2019, an estimated $13.1M.
KBC Group first reported a position in Athenahealth, Inc. in Q2 2016 and held it in 7 quarters.
KBC Group's Athenahealth, Inc. position peaked at $13.1M in Q4 2018.
0 funds tracked by Wall St. Rank held Athenahealth, Inc. as of Q1 2019.

Based on KBC Group's 13F filing for Q1 2019, filed 10 May 2019.